The Relationship Between Early Respiratory Viral Infections and Subsequent Wheezing and Asthma

Martinez FD , Morgan WJ , Wright AL , Holberg CJ , Taussig LM Diminished lung function as a predisposing factor for wheezing respiratory illness in infants. N Engl J Med. 1988;319:1112-1117.

DiFranza JR , Aligne CA , Weitzman M. Prenatal and postnatal environmental tobacco smoke exposure and children's health. Pediatrics. 2004;113(4 suppl):1007-1015.

Arshad SH , Kurukulaaratchy RJ , Fenn M. , Matthews S. Early life risk factors for current wheeze, asthma, and bronchial hyperresponsiveness at 10 years of age. Chest. 2005;127:502-508.

Gold DR , Tager IB , Weiss ST , Tosteson TD , Speizer FE Acute lower respiratory illness in childhood as a predictor of lung function and chronic respiratory symptoms. Am Rev Respir Dis. 1989;140:877-884.

Gold DR , Burge HA , Carey V. , Milton DK , Platts-Mills T. , Weiss ST Predictors of repeated wheeze in the first year of life: the relative roles of cockroach, birth weight, acute lower respiratory illness, and maternal smoking. Am J Respir Crit Care Med. 1999; 160:227-236.

Anderson LJ , Parker RA , Strikas RA , et al. Day-care center attendance and hospitalization for lower respiratory tract illness. Pediatrics. 1988;82:300-308.

Marbury MC , Maldonado G. , Waller L. Lower respiratory illness, recurrent wheezing, and day care attendance. Am J Respir Crit Care Med. 1997;155:156-161.

Martinez FD , Wright AL , Taussig LM , Holberg CJ , Halonen M. , Morgan WJ , for the Group Health Medical Associates. Asthma and wheezing in the first six years of life. N Engl J Med. 1995;332:133-138.

Ly NP , Gold DR , Weiss ST , Celedon JC Recurrent wheeze in early childhood and asthma among children at risk for atopy. Pediatrics. 2006;117:e1132-e1138.

Mallol J. , Andrade R. , Auger F. , Rodriguez J. , Alvarado R. , Figueroa L. Wheezing during the first year of life in infants from low-income population: a descriptive study. Allergol Immunopathol (Madr). 2005;33:257-263.

American Lung Association. Lung Disease Data: 2006. Available at: http://www.lungusa.org/site/apps/s/content.asp?c=dvLUK9O0E&b=34706&ct=67648. Accessed September 14, 2006.

Johnston SL , Pattemore PK , Sanderson G. , et al. Community study of role of viral infections in exacerbations of asthma in 9-11 year old children. BMJ. 1995; 310:1225-1229.

Pullan CR , Hey EN Wheezing, asthma, and pulmonary dysfunction 10 years after infection with respiratory syncytial virus in infancy. Br Med J (Clin Res Ed). 1982; 284:1665-1669.

Sigurs N. , Bjarnason R. , Sigurbergsson F, Kjellman B, Björkstén B. Asthma and immunoglobulin E antibodies after respiratory syncytial virus bronchiolitis: a prospective cohort study with matched controls. Pediatrics. 1995;95:500-505.

Sigurs N. , Bjarnason R. , Sigurbergsson F. , Kjellman B. Respiratory syncytial virus bronchiolitis in infancy is an important risk factor for asthma and allergy at age 7. Am J Respir Crit Care Med. 2000;161:1501-1507.

Kotaniemi-Syrjänen A. , Vainionpää R. , Reijonen TM , Waris M. , Korhonen K. , Korppi M. Rhinovirus-induced wheezing in infancy—the first sign of childhood asthma? J Allergy Clin Immunol. 2003;111:66-71.

Lemanske RF Jr, Jackson DJ , Gangnon RE , et al. Rhinovirus illnesses during infancy predict subsequent childhood wheezing. J Allergy Clin Immunol. 2005;116: 571-577.

Glezen WP , Taber LH , Frank AL , Kasel JA Risk of primary infection and reinfection with respiratory syncytial virus . Am J Dis Child. 1986;140:543-546.

Thompson WW , Shay DK , Weintraub E. , et al. Mortality associated with influenza and respiratory syncytial virus in the United States. JAMA. 2003;289:179-186.

Shay DK , Holman RC , Roosevelt GE , Clarke MJ , Anderson LJ Bronchiolitis-associated mortality and estimates of respiratory syncytial virus—associated deaths among US children, 1979-1997. J Infect Dis. 2001; 183:16-22.

Leader S. , Kohlhase K. Recent trends in severe respiratory syncytial virus (RSV) among US infants, 1997 to 2000. J Pediatr. 2003;143(5 suppl):S127-S132.

Hall CB Respiratory syncytial virus. In: Feigin RD , Cherry JD , eds. Textbook of Pediatric Infectious Diseases. Philadelphia, Pa: WB Saunders Co; 1998:2087.

Shay DK , Holman RC , Newman RD , Liu LL , Stout JW , Anderson LJ Bronchiolitis-associated hospitalizations among US children, 1980-1996. JAMA. 1999;282: 1440-1446.

Langley JM , LeBlanc JC , Smith B. , Wang EE Increasing incidence of hospitalization for bronchiolitis among Canadian children, 1980-2000. J Infect Dis. 2003;188: 1764-1767.

Colasurdo GN , Hemming VG , Prince GA , Gelfand AS , Loader JE , Larsen GL Human respiratory syncytial virus produces prolonged alterations of neural control in airways of developing ferrets. Am J Respir Crit Care Med. 1998;157:1506-1511.

Piedimonte G. Contribution of neuroimmune mechanisms to airway inflammation and remodeling during and after respiratory syncytial virus infection. Pediatr Infect Dis J. 2003 ;22(2 suppl):S66-S74; discussion S74-S75.

Piedimonte G. , Rodriguez MM , King KA , McLean S. , Jiang X. Respiratory syncytial virus upregulates expression of the substance P receptor in rat lungs. Am J Physiol. 1999;277:L831-L840.

King KA , Hu C. , Rodriguez MM , Romaguera R. , Jiang X. , Piedimonte G. Exaggerated neurogenic inflammation and substance P receptor upregulation in RSV-infected wean-ling rats. Am J Respir Cell Mol Biol. 2001;24:101-107.

Piedimonte G. , King KA , Holmgren NL , Bertrand PJ , Rodriguez MM , Hirsch RL A humanized monoclonal antibody against respiratory syncytial virus (palivizumab) inhibits RSV-induced neurogenic-mediated inflammation in rat airways. Pediatr Res. 2000;47:351-356.

Tripp RA , Moore D. , Winter J. , Anderson LJ Respiratory syncytial virus infection and G and/or SH protein expression contribute to substance P, which mediates inflammation and enhanced pulmonary disease in BALB/c mice. J Virol. 2000;74:1614-1622.

Tripp RA , Barskey A. , Goss L. , Anderson LJ Substance P receptor expression on lymphocytes is associated with the immune response to respiratory syncytial virus infection. J Neuroimmunol. 2002;129:141-153.

Jafri HS , Chávez-Bueno S. , Mejías A. , et al. Respiratory syncytial virus induces pneumonia, cytokine response, airway obstruction, and chronic inflammatory infiltrates associated with long-term airway hyperresponsiveness in mice. J Infect Dis. 2004;189:1856-1865.

Openshaw Pjm , Yamaguchi Y. , Tregoning JS Childhood infections, the developing immune system, and the origins of asthma. J Allergy Clin Immunol. 2004; 114:127 5-1277.

Culley FJ , Pollott J. , Openshaw Pjm. Age at first viral infection determines the pattern of T cell—mediated disease during reinfection in adulthood. J Exp Med. 2002; 196:1381-1386.

Dakhama A. , Park JW , Taube C. , et al. The enhancement or prevention of airway hyperresponsiveness during reinfection with respiratory syncytial virus is critically dependent on the age at first infection and IL-13 production. J Immunol. 2005;175:1876-1883.

Dakhama A. , Lee YM , Gelfand EW Virus-induced airway dysfunction: pathogenesis and biomechanisms. Pediatr Infect Dis J. 2005;24(11 suppl):S159-S169, discussion S166-S167.

Gern JE , Brooks GD , Meyer P. , et al. Bidirectional interactions between viral respiratory illnesses and cytokine responses in the first year of life. J Allergy Clin Immunol. 2006;1 17:72-78.

O'Donnell DR , Openshaw PJ Anaphylactic sensitization to aeroantigen during respiratory virus infection. Clin Exp Allergy. 1998;28:1501-1508.

Kristjansson S. , Bjarnarson SP , Wennergren G. , et al. Respiratory syncytial virus and other respiratory viruses during the first 3 months of life promote a local TH2-like response. J Allergy Clin Immunol. 2005;116:805-811.

Openshaw PJ Potential therapeutic implications of new insights into respiratory syncytial virus disease. Respir Res. 2002;(3 suppl 1):S15-S20.

Kim CK , Chung CY , Choi SJ , Kim DK , Park Y. , Koh YY Bronchoalveolar lavage cellular composition in acute asthma and acute bronchiolitis . J Pediatr. 2000;137:517-522.

Kim CK , Kim SW , Park CS , Kim BI , Kang H. , Koh YY Bronchoalveolar lavage cytokine profiles in acute asthma and acute bronchiolitis . J Allergy Clin Immunol. 2003;112:64-71.

Ehlenfield DR , Cameron K. , Welliver RC Eosinophilia at the time of respiratory syncytial virus bronchiolitis predicts childhood reactive airway disease. Pediatrics. 2000;105:79-83.

Welliver RC , Wong DT , Sun M. , Middleton E. Jr, Vaughan RS , Ogra PL The development of respiratory syncytial virus-specific IgE and the release of histamine in nasopharyngeal secretions after infection . N Engl J Med. 1981;305:841-846.

Welliver RC , Sun M. , Rinaldo D. , Ogra PL Predictive value of respiratory syncytial virus-specific IgE responses for recurrent wheezing following bronchiolitis . J Pediatr. 1986;109:776-780.

Dakhama A. , Park JW , Taube C. , et al. The role of virus-specific immunoglobulin E in airway hyperresponsiveness . Am J Respir Crit Care Med. 2004;170:952-959.

Welliver RC , Wong DT , Middleton E. Jr, Sun M. , McCarthy N. , Ogra PL Role of parainfluenza virus-specific IgE in pathogenesis of croup and wheezing subsequent to infection. J Pediatr. 1982;101:889-896.

Henry RL , Hodges IG , Milner AD , Stokes GM Respiratory problems 2 years after acute bronchiolitis in infancy. Arch Dis Child. 1983;58:713-716.

Webb MS , Henry RL , Milner AD , Stokes GM , Swarbrick AS Continuing respiratory problems three and a half years after acute viral bronchiolitis . Arch Dis Child. 1985;60:1064-1067.

Hall CB , Hall WJ , Gala CL , MaGill FB , Leddy JP Long-term prospective study in children after respiratory syncytial virus infection. J Pediatr. 1984;105:358-364.

Sigurs N. , Gustafsson PM , Bjarnason R. , et al. Severe respiratory syncytial virus bronchiolitis in infancy and asthma and allergy at age 13. Am J Respir Crit Care Med. 2005;171:137-141.

Stein RT , Sherrill D. , Morgan WJ , et al. Respiratory syncytial virus in early life and risk of wheeze and allergy by age 13 years. Lancet. 1999;354:541-545.

Korppi M. , Piippo-Savolainen E. , Korhonen K. , Remes S. Respiratory morbidity 20 years after RSV infection in infancy. Pediatr Pulmonol. 2004;38:155-160.

Kneyber Mcj , Steyerberg EW , de Groot R. , Moll HA Long-term effects of respiratory syncytial virus (RSV) bronchiolitis in infants and young children: a quantitative review. Acta Paediatr. 2000;89:654-660.

Noble V. , Murray M. , Webb Msc , Alexander J. , Swarbrick AS , Milner AD Respiratory status and allergy nine to 10 years after acute bronchiolitis . Arch Dis Child. 1997; 76:315-319.

Tepper RS , Rosenberg D. , Eigen H. Airway responsiveness in infants following bronchiolitis. Pediatr Pulmonol. 1992;13:6-10.

Proud D. , Chow CW Role of viral infections in asthma and chronic obstructive pulmonary disease . Am J Respir Cell Mol Biol. 2006;35:513-518.

Williams JV , Harris PA , Tollefson SJ , et al. Human metapneumovirus and lower respiratory tract disease in otherwise healthy infants and children. N Engl J Med. 2004;350:443-450.

Lugo RA , Nahata MC Pathogenesis and treatment of bronchiolitis. Clin Pharm. 1993;12:95-116.

Randolph AG , Wang EE Ribavirin for respiratory syncytial virus infection of the lower respiratory tract. Cochrane Database Syst Rev. 2000:CD000181.

Snell NJ Economic and long-term benefits of ribavirin therapy on respiratory syncytial virus infection. Lung. 1990;168(suppl):422-429.

Simoes Eaf. Treatment and prevention of respiratory syncytial virus lower respiratory tract infection. Long-term effects on respiratory outcomes. Am J Respir Crit Care Med. 2001;163:S14-S17.

Domachowske JB , Rosenberg HF Advances in the treatment and prevention of severe viral bronchiolitis. Pediatr Ann. 2005 ;34:35-41.

Kneyber MC , Kimpen JL Advances in respiratory syncytial virus vaccine development. Curr Opin Investig Drugs. 2004;5:163-170.

Polack FP , Karron RA The future of respiratory syncytial virus vaccine development. Pediatr Infect Dis J. 2004;23(1 suppl):S65-S73.

The PREVENT Study Group. Reduction of respiratory syncytial virus hospitalization among premature infants and infants with bronchopulmonary dysplasia using respiratory syncytial virus immune globulin prophylaxis. Pediatrics. 1997;99:93-99.

The IMpact-RSV Study Group. Palivizumab, a humanized respiratory syncytial virus monoclonal antibody, reduces hospitalization from respiratory syncytial virus infection in high-risk infants. Pediatrics. 1998;102:531-537.

Wenzel SE , Gibbs RL , Lehr MV , Simoes Eaf. Respiratory outcomes in high-risk children 7 to 10 years after prophylaxis with respiratory syncytial virus immune globulin. Am J Med. 2002;112:627-633.

Simoes Eaf , Carbonell-Estrany X. , Kimpen J. , et al. Palivizumab use decreases risk of recurrent wheezing in preterm children [abstract]. Eur Respir J. 2004;24:212S.

Mejias A. , Chavez-Bueno S. , Rios AM , et al. Comparative effects of two neutralizing anti-respiratory syncytial virus (RSV) monoclonal antibodies in the RSV murine model: time versus potency . Antimicrob Agents Chemother. 2005;49:4700-4707.

Venkatesh MP , Weisman LE Prevention and treatment of respiratory syncytial virus infection in infants: an update. Expert Rev Vaccines . 2006;5:261-268.

Hayden FG Respiratory viral threats. Curr Opin Infect Dis. 2006;19:169-178.